Burning rock and boehringer ingelheim achieved a master service agreement in oncology companion diagnostics

Guangzhou, china, oct. 30, 2023 (globe newswire) -- burning rock biotech limited (nasdaq: bnr and lse: bnr, the “company” or “burning rock”) is pleased to announce that the company and boehringer ingelheim officially have signed the master service agreement (msa) in the field of oncology companion diagnostics. this agreement aims to provide chinese patients with safer, more efficient, and precise treatment options and diagnostic methods, thereby promoting innovation and development in cancer treatment.
BNR Ratings Summary
BNR Quant Ranking